Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

When it comes to achieving that perfect mash though, people rely on loads of different methods – each household has their own way of doing it. I’ve delved so heavily into potato recipes over ...

'Stressful times': This market is scary. Here's why not to pull your money out ...

Add galleries to your saved list and come back to them any time.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...